|
RNF26 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.719800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.258200E-02 |
| Normal-vs-Stage2 |
1.047410E-01 |
| Normal-vs-Stage3 |
2.598800E-01 |
| Normal-vs-Stage4 |
4.077800E-01 |
| Stage1-vs-Stage2 |
6.872000E-01 |
| Stage1-vs-Stage3 |
7.812600E-01 |
| Stage1-vs-Stage4 |
1.163020E-01 |
| Stage2-vs-Stage3 |
9.719800E-01 |
| Stage2-vs-Stage4 |
8.228500E-02 |
| Stage3-vs-Stage4 |
2.419600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.069770E-02 |
| Normal-vs-AfricanAmerican |
2.077900E-02 |
| Normal-vs-Asian |
6.408600E-01 |
| Caucasian-vs-AfricanAmerican |
6.988000E-01 |
| Caucasian-vs-Asian |
1.650040E-01 |
| AfricanAmerican-vs-Asian |
3.700600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.312200E-02 |
| Normal-vs-Female |
7.52510000000539E-05 |
| Male-vs-Female |
2.195800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.451600E-01 |
| Normal-vs-Extreme_Weight |
5.845000E-01 |
| Normal-vs-Obese |
2.863100E-03 |
| Normal-vs-Extreme_Obese |
5.234200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.292000E-01 |
| Normal_Weight-vs-Obese |
6.214100E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.490400E-01 |
| Extreme_Weight-vs-Obese |
1.236230E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.182000E-01 |
| Obese-vs-Extreme_Obese |
3.588800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.879900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.978800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.856830E-01 |
| Normal-vs-Age(81-100Yrs) |
8.525000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.029500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.199740E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.626030E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.362000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.679200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.819800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.916400E-03 |
| Normal-VS-Type2 PRCC |
8.810400E-01 |
| Normal-VS-KIRP CIMP |
9.440900E-03 |
| Normal-VS-Unclassified PRCC |
1.177900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.324440E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.140740E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.650400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.157500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.717500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.061700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.467400E-01 |
| Normal-vs-N1 |
3.184000E-01 |
| Normal-vs-N2 |
8.695600E-01 |
| N0-vs-N1 |
4.951200E-01 |
| N0-vs-N2 |
7.043400E-01 |
| N1-vs-N2 |
5.864400E-01 |
|
|
